Hidetomo Kitamura

894 total citations
22 papers, 588 citations indexed

About

Hidetomo Kitamura is a scholar working on Molecular Biology, Rheumatology and Genetics. According to data from OpenAlex, Hidetomo Kitamura has authored 22 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Rheumatology and 4 papers in Genetics. Recurrent topics in Hidetomo Kitamura's work include Osteoarthritis Treatment and Mechanisms (4 papers), Connective tissue disorders research (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Hidetomo Kitamura is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (4 papers), Connective tissue disorders research (3 papers) and Inflammatory mediators and NSAID effects (3 papers). Hidetomo Kitamura collaborates with scholars based in Japan, United States and Norway. Hidetomo Kitamura's co-authors include Naoaki Murao, Eri Kondo, Kazuwa Nakao, Toshihito Fujii, Akihiro Yasoda, Atsuhiko Kato, Hideki Adachi, Haruhiko Sato, Etsuko Fujii and Tatsuya Tamura and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hidetomo Kitamura

22 papers receiving 572 citations

Peers

Hidetomo Kitamura

GENET

RHEUM

DERMA

Walter Voigt United States

Raquel Grau Spain

Katsuhiko Shinomiya Japan

Guanmei Wen China

Pal Göőz United States

Evert Nijhuis Netherlands

Laëtitia Gorisse France

Roland Blanqué Belgium

Igor Hrgović Germany

Asta Valančiūtė France

Walter Voigt United States

Hidetomo Kitamura

160 ×0.7

100 ×0.9

GENET

55 ×0.6

RHEUM

130 ×1.4

DERMA

13 ×0.2

Citations per year, relative to Hidetomo Kitamura Hidetomo Kitamura (= 1×) peers Walter Voigt

Countries citing papers authored by Hidetomo Kitamura

Since Specialization

Citations

This map shows the geographic impact of Hidetomo Kitamura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetomo Kitamura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetomo Kitamura more than expected).

Fields of papers citing papers by Hidetomo Kitamura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetomo Kitamura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetomo Kitamura. The network helps show where Hidetomo Kitamura may publish in the future.

Co-authorship network of co-authors of Hidetomo Kitamura

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetomo Kitamura. A scholar is included among the top collaborators of Hidetomo Kitamura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetomo Kitamura. Hidetomo Kitamura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsui, Katsuma, Masatoshi Matsumoto, Naoki Kawamura, et al.. (2023). 2524. Safety and Pharmacokinetics of PA-001, a New Potential COVID-19 Drug That Targets the S2 Subunit of SARS-CoV-2 Spike Protein, in Healthy Subjects. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Kawamura, Tatsuro, Hirofumi Ohashi, Naoko Iwata‐Yoshikawa, et al.. (2023). 2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Nishimura, Yoshikazu, Yoshiaki Isshiki, Takashi Emura, et al.. (2020). Lead Optimization and Avoidance of Reactive Metabolite Leading to PCO371, a Potent, Selective, and Orally Available Human Parathyroid Hormone Receptor 1 (hPTHR1) Agonist. Journal of Medicinal Chemistry. 63(10). 5089–5099. 15 indexed citations

Yamaguchi, Kazuki, Tetsuhiro Soeda, Motohiko Sato, et al.. (2020). Pharmacology and Pharmacokinetics of NXT007; Emicizumab-Based Engineered Fixa/Fx Bispecific Antibody with Improved Properties. Blood. 136(Supplement 1). 19–19. 4 indexed citations

Soeda, Tetsuhiro, Atsunori Ueyama, Atsushi Muto, et al.. (2018). Emicizumab, A Bispecific Antibody to Factors IX/IXa and X/Xa, Does Not Interfere with Antithrombin or TFPI Activity In Vitro. SHILAP Revista de lepidopterología. 2(1). e96–e103. 15 indexed citations

Tamura, Tatsuya, Yoshinobu Higuchi, Hidetomo Kitamura, et al.. (2016). Novel hyaluronic acid–methotrexate conjugate suppresses joint inflammation in the rat knee: efficacy and safety evaluation in two rat arthritis models. Arthritis Research & Therapy. 18(1). 121–121. 46 indexed citations

Tamura, Tatsuya, Hiroshi Noda, Tomoyuki Watanabe, et al.. (2016). Identification of an orally active small-molecule PTHR1 agonist for the treatment of hypoparathyroidism. Nature Communications. 7(1). 13384–13384. 52 indexed citations

Kitamura, Hidetomo, Taichi Kuramochi, Yoshinobu Higuchi, et al.. (2016). Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody. Experimental Dermatology. 27(1). 14–21. 41 indexed citations

Fujii, Etsuko, et al.. (2014). Anti‐IL‐31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. British Journal of Pharmacology. 171(22). 5049–5058. 65 indexed citations

10.

Kitamura, Hidetomo, Yuichiro Adachi, Tetsuro Yoshioka, et al.. (2009). Chronically elevated plasma C-type natriuretic peptide level stimulates skeletal growth in transgenic mice. American Journal of Physiology-Endocrinology and Metabolism. 297(6). E1339–E1348. 75 indexed citations

11.

Yasoda, Akihiro, Hidetomo Kitamura, Toshihito Fujii, et al.. (2009). Systemic Administration of C-Type Natriuretic Peptide as a Novel Therapeutic Strategy for Skeletal Dysplasias. Endocrinology. 150(7). 3138–3144. 92 indexed citations

12.

Yasoda, Akihiro, Hidetomo Kitamura, Toshihito Fujii, et al.. (2009). Systemic Administration of C-Type Natriuretic Peptide as a Novel Therapeutic Strategy for Skeletal Dysplasias. The Journal of Clinical Endocrinology & Metabolism. 94(5). 1835–1835. 3 indexed citations

13.

Kitamura, Hidetomo & Makoto Okazaki. (2005). AG-041R, a novel indoline-2-one derivative, stimulates chondrogenesis in a bipotent chondroprogenitor cell line CL-1. Osteoarthritis and Cartilage. 13(4). 287–296. 11 indexed citations

14.

Okazaki, Makoto, Y. Higuchi, & Hidetomo Kitamura. (2003). AG-041R stimulates cartilage matrix synthesis without promoting terminal differentiation in rat articular chondrocytes. Osteoarthritis and Cartilage. 11(2). 122–132. 10 indexed citations

15.

Kitamura, Hidetomo. (2003). Establishment of a bipotent cell line CL-1 which differentiates into chondrocytes and adipocytes from adult mouse. Osteoarthritis and Cartilage. 12(1). 25–37. 5 indexed citations

16.

Furuichi, Tatsuya, Keigo Yorozu, Satoshi Kawata, et al.. (2002). Effects of i.v. and oral 1,25-dihydroxy-22-oxavitamin D3 on secondary hyperparathyroidism in dogs with chronic renal failure. Nephrology Dialysis Transplantation. 17(suppl 10). 46–52. 13 indexed citations

17.

Kitamura, Hidetomo, et al.. (2001). AG-041R, a novel indoline-2-one derivative, induces systemic cartilage hyperplasia in rats. European Journal of Pharmacology. 418(3). 225–230. 42 indexed citations

18.

Kitamura, Hidetomo, et al.. (2000). Enhancement of intestinal lgA levels in piglets by oral administration of a commercially available casein phosphopeptide preparation.. Milk science international/Milchwissenschaft. 55(8). 429–432. 13 indexed citations

19.

Imazeki, Ikuo, Naoshi Fukushima, Fumiaki Takahashi, et al.. (1997). Safety and kinetic properties of a humanized antibody to human interleukin-6 receptor in healthy non-human primates. Toxicology. 122(3). 163–170. 3 indexed citations

20.

Kimura, Takahiro, Takehiko Kobayashi, Takuya Iida, et al.. (1995). [Effect of 5'-deoxy-5-fluorouridine (5'-DFUR) on the activity of pyrimidine nucleoside phosphorylase (pyNPase) in normal and tumor tissues of human stomach].. PubMed. 22(8). 1051–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact